226 related articles for article (PubMed ID: 28208879)
1. Carbamazepine-induced Life-threatening Stevens-Johnson Syndrome and Agranulocytosis: The Maiden Case.
Avinash A; Amberkar VM; Kunder SK; Madhyastha S; Meenakumari K
J Clin Diagn Res; 2016 Dec; 10(12):FD01-FD03. PubMed ID: 28208879
[TBL] [Abstract][Full Text] [Related]
2. The Co-Existence of Agranulocytosis and Stevens-Johnson Syndrome (SJS) in Carbamazepine Therapy: A Case Report.
Batool S; Voloshyna D; Usama M; Suleman M; Sandhu QI; Nepal L; Ghobriel NG; Mengar J; Mohammed Rasmy AS
Cureus; 2022 Sep; 14(9):e28917. PubMed ID: 36237740
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study.
Syu FK; Pan HY; Chuang PC; Huang YS; Cheng CY; Cheng FJ
J Dermatol; 2018 Sep; 45(9):1080-1087. PubMed ID: 29963717
[TBL] [Abstract][Full Text] [Related]
4. Successful Treatment of a Paroxysmal Kinesigenic Dyskinesia Patient with Carbamazepine-Induced Stevens-Johnson Syndrome Using Oxcarbazepine Monotherapy: A Case Report.
Tran HT; Nguyen KV; Vercueil L
Case Rep Neurol; 2021; 13(3):598-604. PubMed ID: 34703449
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptic Drugs-induced Stevens-Johnson syndrome: A case Series.
Trivedi BS; Darji NH; Malhotra SD; Patel PR
J Basic Clin Pharm; 2016 Dec; 8(1):42-44. PubMed ID: 28104975
[TBL] [Abstract][Full Text] [Related]
6. Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepine-induced Stevens-Johnson syndrome.
Huang LY; Liao WC; Chiou CC; Lou JP; Hu P; Ko FC
J Formos Med Assoc; 2007 Dec; 106(12):1032-7. PubMed ID: 18194909
[TBL] [Abstract][Full Text] [Related]
7. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
Boruah PK; Bolesta S; Shetty SM
Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
[TBL] [Abstract][Full Text] [Related]
8. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.
Frey N; Bodmer M; Bircher A; Rüegg S; Jick SS; Meier CR; Spoendlin J
Epilepsia; 2017 Dec; 58(12):2178-2185. PubMed ID: 29027197
[TBL] [Abstract][Full Text] [Related]
9. Suspected lamotrigine-induced toxic epidermal necrolysis.
Chaffin JJ; Davis SM
Ann Pharmacother; 1997 Jun; 31(6):720-3. PubMed ID: 9184711
[TBL] [Abstract][Full Text] [Related]
10. Stevens-johnson syndrome induced by carbamazepine treatment in a patient who previously had carbamazepine induced pruritus - a case report -.
Bae HM; Park YJ; Kim YH; Moon DE
Korean J Pain; 2013 Jan; 26(1):80-3. PubMed ID: 23342214
[TBL] [Abstract][Full Text] [Related]
11. The association of HLA B*15:02 allele and Stevens-Johnson syndrome/toxic epidermal necrolysis induced by aromatic anticonvulsant drugs in a South Indian population.
Devi K
Int J Dermatol; 2018 Jan; 57(1):70-73. PubMed ID: 29076187
[TBL] [Abstract][Full Text] [Related]
12. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
[TBL] [Abstract][Full Text] [Related]
13. [Lyell syndrome and Stevens-Johnson syndrome caused by lamotrigine].
Bocquet H; Farmer M; Bressieux JM; Barzegar C; Jullien M; Soto B; Roujeau JC; Revuz J
Ann Dermatol Venereol; 1999 Jan; 126(1):46-8. PubMed ID: 10095893
[TBL] [Abstract][Full Text] [Related]
14. Phenytoin-induced Stevens-Johnson syndrome with myocarditis: a rare case report.
Kodliwadmath A
Int Med Case Rep J; 2017; 10():229-231. PubMed ID: 28744164
[TBL] [Abstract][Full Text] [Related]
15. [Lamotrigine induced hypersensitivity syndrome in children: a case report].
Cui NX; Zhu XP
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 51(2):356-358. PubMed ID: 30996382
[TBL] [Abstract][Full Text] [Related]
16. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.
Rzany B; Correia O; Kelly JP; Naldi L; Auquier A; Stern R
Lancet; 1999 Jun; 353(9171):2190-4. PubMed ID: 10392983
[TBL] [Abstract][Full Text] [Related]
17. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J
Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335
[TBL] [Abstract][Full Text] [Related]
18. Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications.
Bermeo-Ovalle A
Epilepsy Curr; 2019; 19(2):96-98. PubMed ID: 30955419
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Lymphocyte Transformation Test Results in Patients with Delayed Hypersensitivity Reactions following the Use of Anticonvulsant Drugs.
Karami Z; Mesdaghi M; Karimzadeh P; Mansouri M; Taghdiri MM; Kayhanidoost Z; Jebelli B; Shekarriz Foumani R; Babaie D; Chavoshzadeh Z
Int Arch Allergy Immunol; 2016; 170(3):158-62. PubMed ID: 27560351
[TBL] [Abstract][Full Text] [Related]
20. [Drug-induced Stevens-Johnson syndrome in a patient with AIDS].
Schlienger RG; Haefeli WE; Bircher A; Leib SL; Lüscher TF
Schweiz Rundsch Med Prax; 1993 Aug; 82(33):888-92. PubMed ID: 8372290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]